Clegg calls for further delay to Health Bill
May 27, 2011Health and Social Care Bill, NHS reforms
The government should amend its NHS reform plans and then allow them to be scrutinised further by MPs, the Deputy …
Digital Pharma: Roche launches online warfarin training for patients
May 27, 2011Medical Communications Digital Pharma blog, Roche, anticoagulant, warfarin
Roche has launched an online training tool to help UK patients on long-term warfarin learn about anticoagulation self-monitoring. The CoaguChek …
J&J aims for Japanese pharma expansion
May 27, 2011Research and Development, Sales and Marketing J&J, JJ
Johnson & Johnson has identified Japan as a key growth market for its pharma business as it outlines its strategic …
Bayer contraceptive advert breaches Code of Practice
May 27, 2011Medical Communications ABPI Code of Practice, Bayer, Multaq, Sanofi, Yasmin
Bayer Healthcare has been singled out for “particular censure” by the PMCPA, the body which regulates the ABPI Code of …
Chandler Chicco wins award for work on Botox migraine launch
May 27, 2011Medical Communications Chandler Chicco, awards, medical communications
Chandler Chicco Agency has won an award for its work on the launch of Botox’s chronic migraine indication in the …
Digital Pharma: More painful progress for NHS electronic records
May 26, 2011Medical Communications Digital Pharma blog, IT, NHS, electronic patient records
The NHS’ plans for electronic patient records are in tatters, dogged by missed deadlines, poor value for money and a …
Pharma faces ‘trench warfare’ with NHS
May 26, 2011Sales and Marketing Cost cutting, NHS, prescribing
The competing interests of the NHS and the pharma industry could end in trench warfare, a leading NHS figure has …
BMA calls for major amendments to Health Bill
May 26, 2011Health and Social Care Bill, NHS reforms
The BMA says the government should withdraw its plans for health reform completely and go back to the drawing board. …
British biotech: rebuilding momentum
May 26, 2011Research and Development UK, biotech, biotech funding
Since biotech first emerged in the UK in the late 1980s, the dream has always been for the country to …
NICE to appraise hep C drugs Victrelis and telaprevir
May 26, 2011Sales and Marketing Brinavess, Ilaris, NICE, Victrelis, Xarelto, Zytiga, telaprevir
NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …
GSK’s Trobalt launched in UK
May 25, 2011Sales and Marketing GlaxoSmithKline, Trobalt, epilepsy, retigabine
GSK has launched its new epilepsy treatment Trobalt in the UK. Trobalt (retigabine) is as adjunctive treatment of partial onset …
Elan signs $20m research deal with Proteostasis
May 25, 2011Research and Development Elan, Proteostasis, neurodegenerative diseases
Elan Corporation has signed a deal with US small molecule drug specialist Proteostasis Therapeutics to develop products for conditions such …
Eisai extends neuroscience partnership with UCL
May 25, 2011Research and Development Eisai, UCL, academic alliance, academic research, neurodegenerative diseases
Eisai and University College London are to extend their partnership in neuroscience research. The Japanese company’s Neuroscience Product Creation Unit …
Contract research news in brief
May 25, 2011Research and Development contract research, contract research news
Mergers and acquisitions abound in our latest round-up of contract research sector news, as players try to achieve the global …
Mark Duckham joins Adventis Health
May 25, 2011Medical Communications appointment, medical communications
Adventis Health has appointed Mark Duckham to the newly-created role of client services director. In his new position Mark will …
NICE U-turn on Roche’s MabThera
May 25, 2011Sales and Marketing MabThera, NICE, Roche
NICE has provisionally recommended Roche’s MabThera as a maintenance therapy for blood cancer patients. The new draft guidance backs MabThera’s …
Pfizer will invest $21m in US injectables upgrade
May 25, 2011Manufacturing and Production APIs, Pfizer, pharma manufacturing
Pfizer has announced another upgrade of its sterile injectables plant in Portage, Michigan, earmarking around $21 million for new air …
IPA Best of Health Awards shortlist revealed
May 25, 2011Medical Communications Best of Health, IPA
The short list of agencies selected for this year’s IPA Best of Health Awards has been revealed. The IPA’s awards …
Wainwright Associates offer more Free Pharmacovigilance and Regulatory Affairs Webinars
May 24, 2011Business Services Wainwright Associates; free webinars for Pharmacovigilance and Regulatory Affairs
Following the success of the “The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance (QPPV)” webinar delivered on …
J&J and Vertex’s hep C drug Incivek approved by FDA
May 24, 2011Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir
The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
